NasdaqGM:RLAYBiotechs
A Look At Relay Therapeutics (RLAY) Valuation As Shares Rebound And Trade Below Analyst Targets
Relay Therapeutics (RLAY) has caught investor interest after a period of strong one year total return alongside significant multi year drawdowns. This has raised questions about how its current US$9.16 share price reflects those mixed outcomes.
See our latest analysis for Relay Therapeutics.
The recent 1 month share price return of 7.76% and 3 month share price return of 15.66%, alongside a 1 year total shareholder return of 181.85% but weak multi year total shareholder returns, suggest short...